Calmare Therapeutics Receives Favorable Decision From The U.S. Court Of Appeals For The Second Circuit
GEOMC's Petition for Rehearing Denied $10.4 Million Judgment Against Calmare Therapeutics Vacated FAIRFIELD, CT / ACCESSWIRE / June 3, 2019 / Calmare Therapeutics Incorporated, (OTC PINK: CTTC), the pain mitigation company ("Calmare"), has received a favorable decision from the U.S. Court of Appeals for the Second Circuit (the "Court"), which refused to reconsider its March 2019 decision to vacate a $10.4 million judgment against the Company. On...
Read more









